2018 marks the launch of our new website. We hope you like the fresh new look and improved navigation. The site places our clinical partners centre stage, and shines a light on their compelling research and readiness to embrace innovation to establish new therapies that address significant unmet need.
Reducing VTE risk in acute stroke patients.
Accelerating readiness for theatre in patients requiring Open Reduction Internal Fixation (ORIF).
Preventing the build-up of post-operative oedema in Total Hip Replacement patients.
Providing venous thromboembolism (VTE) prophylaxis to all at risk hospital patients.
Preventing stasis in the deep veins of the calf where early thrombi form.
The revolutionary neuromuscular electrostimulation technology developed by Firstkind
Hospital Applications device